. "Biopsie sentinelov\u00E9 uzliny u kolorekt\u00E1ln\u00EDho karcinomu - pilotn\u00ED studie"@cs . . . "599943" . "0035-9351" . "82" . . . . . "486; 491" . . . "\u00DAvod: Sentinelov\u00E1 biopsie je v indikovan\u00FDch p\u0159\u00EDpadech \u0161iroce akceptov\u00E1na pro staging malign\u00EDho melanomu i karcinomu prsu. Jej\u00ED pou\u017Eit\u00ED u kolorekt\u00E1ln\u00EDho karcinomu je ve stadiu klinick\u00FDch v\u00FDzkum\u016F. C\u00EDlem pilotn\u00ED studie bylo zav\u00E9st metodiku lymfatick\u00E9ho mapov\u00E1n\u00ED a biopsie sentinelov\u00E9 uzliny do klinick\u00E9 praxe u karcinomu tra\u010Dn\u00EDku, zjistit jej\u00ED proveditelnost a p\u0159\u00EDpadn\u00E1 \u00FAskal\u00ED a vyhodnotit prvn\u00ED z\u00EDskan\u00E9 zku\u0161enosti. Metoda: U 20 pacient\u016F bylo provedeno intraopera\u010Dn\u00ED lymfatick\u00E9 mapov\u00E1n\u00ED pomoc\u00EDmetylenov\u00E9 mod\u0159i, fluoresceinunebo radionavigovan\u011B, p\u0159\u00EDpadn\u011B kombinac\u00EDmetod.N\u00E1sledovala standardn\u00ED resekce tra\u010Dn\u00EDku.Z\u00EDskan\u00E9 sentinelov\u00E9 uzliny byly vy\u0161et\u0159eny mikroskopicky s b\u011B\u017En\u00FDm barven\u00EDm hematoxylinem-eozinem i imunohistochemicky. V\u00FDsledky: Lymfatick\u00E9 mapov\u00E1n\u00ED vedlo k identifikaci minim\u00E1ln\u011B jedn\u00E9 sentinelov\u00E9 uzliny (SN) in vivo nebo modifikovanou technikou ex vivo u v\u0161ech 20 pacient\u016F (100 %). Pr\u016Fm\u011Brn\u00FD po\u010Det sentinelov\u00FDch uzlin byl 1,5 (1?3), ostatn\u00EDch uzlin 13,6 (1?38) na jeden resek\u00E1t. V 14 p\u0159\u00EDpadech (70 %) SN spr\u00E1vn" . "P(ND7112)" . "RIV/00209805:_____/03:00007997" . "Biopsie sentinelov\u00E9 uzliny u kolorekt\u00E1ln\u00EDho karcinomu - pilotn\u00ED studie" . "The Biopsy of sentinel node in colorectal cancer - a pilot study"@en . "Background: Sentinel lymph node biopsy is a widely accepted method for staging melanoma and breast cancer in indicated cases. However, the use of the method in colorectal cancer is under clinical investigation. The aim of the pilot study was to introduce the technique into the surgical practice in colon carcinoma, to determine the feasibility and potential problems and to evaluate the first experience. Methods: Twenty patients with colon cancer underwent lymphatic mapping and sentinel node biopsy using blue dye, fluorescein or lymphoscintigraphy followed by standard surgical resection. The acquired sentinel nodes were investigated with both standard hematoxylin-eosin staining and immunohistochemical staining for cytokeratin. Results: Lymphatic mapping adequately identified at least one sentinel node (SN) intraoperatively or by a modified ex vivo technique in 20 patients (100%). The average number of SN was 1.5 (range 1?3), non-SN 13.6 (range 1?38) per patient. SN correctly predicted the regional lymp"@en . . "\u0160efr, Roman" . . "7"^^ . . "9" . "RIV/00209805:_____/03:00007997!RIV/2004/MZ0/L26004/N" . "7"^^ . "Biopsie sentinelov\u00E9 uzliny u kolorekt\u00E1ln\u00EDho karcinomu - pilotn\u00ED studie" . "The Biopsy of sentinel node in colorectal cancer - a pilot study"@en . "colorectal cancer;lymphatic mapping;sentinel node;colon resection;biopsy"@en . "[28DD7A5F65E2]" . . . "Biopsie sentinelov\u00E9 uzliny u kolorekt\u00E1ln\u00EDho karcinomu - pilotn\u00ED studie"@cs . . "CZ - \u010Cesk\u00E1 republika" . "Rozhledy v chirurgii" . . "6"^^ . .